NASDAQ:TECH

Bio-Techne News Headlines

$470.01
-4.39 (-0.93 %)
(As of 07/26/2021 12:52 PM ET)
Add
Compare
Today's Range
$470.00
$475.14
50-Day Range
$387.35
$474.40
52-Week Range
$228.66
$479.00
Volume994 shs
Average Volume224,294 shs
Market Capitalization$18.28 billion
P/E Ratio102.62
Dividend Yield0.27%
Beta1.13

Bio-Techne (NASDAQ TECH) News Headlines Today

SourceHeadline
SVB Leerink Increases Bio-Techne (NASDAQ:TECH) Price Target to $480.00SVB Leerink Increases Bio-Techne (NASDAQ:TECH) Price Target to $480.00
marketbeat.com - June 29 at 8:52 AM
Bio-Techne, J2 Global And InMode Break Out Of Bases, Near Buy PointsBio-Techne, J2 Global And InMode Break Out Of Bases, Near Buy Points
marketbeat.com - June 17 at 4:14 AM
Global GMP Cytokines Market 2021 Production, Revenue, Price Trend by Type, Application, Manufactures and Forecast to 2027Global GMP Cytokines Market 2021 Production, Revenue, Price Trend by Type, Application, Manufactures and Forecast to 2027
marketwatch.com - July 23 at 11:10 PM
Bio-Techne (NASDAQ:TECH) Hits New 52-Week High at $469.70Bio-Techne (NASDAQ:TECH) Hits New 52-Week High at $469.70
americanbankingnews.com - July 20 at 12:44 PM
Host Cell Contaminant Testing Market Report 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Analysis, Revenue, Forecast Report - GlobeNewswireHost Cell Contaminant Testing Market Report 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Analysis, Revenue, Forecast Report - GlobeNewswire
globenewswire.com - July 20 at 7:44 AM
Hedge Funds Are Souring On Bio-Techne Corporation (TECH) - Yahoo FinanceHedge Funds Are Souring On Bio-Techne Corporation (TECH) - Yahoo Finance
finance.yahoo.com - July 20 at 1:04 AM
Hedge Funds Are Souring On Bio-Techne Corporation (TECH)Hedge Funds Are Souring On Bio-Techne Corporation (TECH)
finance.yahoo.com - July 20 at 1:03 AM
Bio-Techne Co. (NASDAQ:TECH) Insider Sells $490,952.43 in StockBio-Techne Co. (NASDAQ:TECH) Insider Sells $490,952.43 in Stock
americanbankingnews.com - July 17 at 10:22 AM
Vir Biotech (VIR) Begins Dosing in Phase II Hepatitis B Study - NasdaqVir Biotech (VIR) Begins Dosing in Phase II Hepatitis B Study - Nasdaq
nasdaq.com - July 16 at 1:07 PM
Best Mutual Funds: This One Bets On These Emerging Stocks - Investors Business DailyBest Mutual Funds: This One Bets On These Emerging Stocks - Investor's Business Daily
investors.com - July 15 at 9:46 AM
Top Columbia Fund Likes These Emerging, Core StocksTop Columbia Fund Likes These Emerging, Core Stocks
finance.yahoo.com - July 15 at 9:46 AM
Bio-Techne Co. (NASDAQ:TECH) CFO James Hippel Sells 10,000 SharesBio-Techne Co. (NASDAQ:TECH) CFO James Hippel Sells 10,000 Shares
americanbankingnews.com - July 14 at 7:08 PM
Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial ResultsBio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results
finance.yahoo.com - July 13 at 8:41 AM
Inhibikase Therapeutics (NYSE:IKT) and Bio-Techne (NASDAQ:TECH) Critical ReviewInhibikase Therapeutics (NYSE:IKT) and Bio-Techne (NASDAQ:TECH) Critical Review
americanbankingnews.com - July 12 at 11:46 AM
Bio-Techne (NASDAQ:TECH) Sets New 52-Week High at $463.50Bio-Techne (NASDAQ:TECH) Sets New 52-Week High at $463.50
americanbankingnews.com - July 7 at 12:33 PM
Why Worry With Dividends? Their Five-Year Reinvested Value for Bio-Techne - BenzingaWhy Worry With Dividends? Their Five-Year Reinvested Value for Bio-Techne - Benzinga
benzinga.com - July 2 at 12:19 PM
Bio-Techne (NASDAQ:TECH) Hits New 1-Year High at $456.03Bio-Techne (NASDAQ:TECH) Hits New 1-Year High at $456.03
americanbankingnews.com - July 1 at 10:50 AM
Bio-techne Announces Opening Of New Ireland FacilityBio-techne Announces Opening Of New Ireland Facility
finance.yahoo.com - June 28 at 9:18 AM
We Think Bio-Techne (NASDAQ:TECH) Can Manage Its Debt With Ease - NasdaqWe Think Bio-Techne (NASDAQ:TECH) Can Manage Its Debt With Ease - Nasdaq
nasdaq.com - June 25 at 5:36 PM
Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing TechnologiesBio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
finance.yahoo.com - June 24 at 9:31 AM
How to Buy Bio-Techne (TECH) Stock Right Now • Benzinga - BenzingaHow to Buy Bio-Techne (TECH) Stock Right Now • Benzinga - Benzinga
benzinga.com - June 23 at 1:31 PM
Announcing: Bio-Techne (NASDAQ:TECH) Stock Soared An Exciting 309% In The Last Five Years - Yahoo FinanceAnnouncing: Bio-Techne (NASDAQ:TECH) Stock Soared An Exciting 309% In The Last Five Years - Yahoo Finance
finance.yahoo.com - June 22 at 5:07 PM
Announcing: Bio-Techne (NASDAQ:TECH) Stock Soared An Exciting 309% In The Last Five YearsAnnouncing: Bio-Techne (NASDAQ:TECH) Stock Soared An Exciting 309% In The Last Five Years
finance.yahoo.com - June 22 at 12:07 PM
Insights on the Flow Cytometry in Oncology Global Market to 2031 - GlobeNewswireInsights on the Flow Cytometry in Oncology Global Market to 2031 - GlobeNewswire
globenewswire.com - June 16 at 8:22 AM
Dow Jones Futures Edge Up With Fed In Focus: Apple Vs. Microsoft Vs. Google; How To Be A Big Stock Market WinnerDow Jones Futures Edge Up With Fed In Focus: Apple Vs. Microsoft Vs. Google; How To Be A Big Stock Market Winner
finance.yahoo.com - June 13 at 7:43 PM
Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing CapabilitiesBio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing Capabilities
finance.yahoo.com - June 10 at 10:49 AM
Bio-Techne Stock Is Estimated To Be Significantly Overvalued - Yahoo FinanceBio-Techne Stock Is Estimated To Be Significantly Overvalued - Yahoo Finance
finance.yahoo.com - June 8 at 9:58 AM
Bio-Techne Stock Shows Rising Strength As The Small Cap Nears Billion-Dollar Run Rate - Investors Business DailyBio-Techne Stock Shows Rising Strength As The Small Cap Nears Billion-Dollar Run Rate - Investor's Business Daily
investors.com - June 7 at 6:15 PM
Bio-Techne Stock Shows Rising Strength As The Small Cap Nears Billion-Dollar Run RateBio-Techne Stock Shows Rising Strength As The Small Cap Nears Billion-Dollar Run Rate
finance.yahoo.com - June 7 at 6:15 PM
Google Stock, Dell Lead Five Stocks Near Buys Showing Strength In 2021 - Investors Business DailyGoogle Stock, Dell Lead Five Stocks Near Buys Showing Strength In 2021 - Investor's Business Daily
investors.com - June 5 at 12:29 PM
3 Stocks With Solid Balance Sheets for the Value Investor - Yahoo Finance3 Stocks With Solid Balance Sheets for the Value Investor - Yahoo Finance
finance.yahoo.com - June 3 at 10:29 PM
Bio-Techne and Kantaro Biosciences get Health Canada authorization for COVID-19 test kit - Seeking AlphaBio-Techne and Kantaro Biosciences get Health Canada authorization for COVID-19 test kit - Seeking Alpha
seekingalpha.com - June 2 at 3:19 PM
Serum-Free Cell Freezing Medium Market Size Growth Rate 2021 Research Report by Challenges, Restraints, Sales Estimates and Forecast to 2027Serum-Free Cell Freezing Medium Market Size Growth Rate 2021 Research Report by Challenges, Restraints, Sales Estimates and Forecast to 2027
marketwatch.com - May 30 at 7:23 AM
IBD Rating Upgrades: Bio-Techne Flashes Improved Technical Strength - Investors Business DailyIBD Rating Upgrades: Bio-Techne Flashes Improved Technical Strength - Investor's Business Daily
investors.com - May 21 at 8:26 PM
Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic ApplicationsBio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications
finance.yahoo.com - May 18 at 7:40 AM
Here’s Why Baron Funds Became Bullish in Bio-Techne Corp. (TECH) - Yahoo FinanceHere’s Why Baron Funds Became Bullish in Bio-Techne Corp. (TECH) - Yahoo Finance
finance.yahoo.com - May 13 at 11:20 PM
Here’s Why Baron Funds Became Bullish in Bio-Techne Corp. (TECH)Here’s Why Baron Funds Became Bullish in Bio-Techne Corp. (TECH)
finance.yahoo.com - May 13 at 11:20 PM
Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for May 14, 2021 - NasdaqBio-Techne Corp (TECH) Ex-Dividend Date Scheduled for May 14, 2021 - Nasdaq
nasdaq.com - May 13 at 12:05 PM
Ex-Dividend Reminder: American States Water, Fortis and Bio-Techne - NasdaqEx-Dividend Reminder: American States Water, Fortis and Bio-Techne - Nasdaq
nasdaq.com - May 12 at 11:02 AM
Is Bio-Techne Corporations (NASDAQ:TECH) Latest Stock Performance Being Led By Its Strong Fundamentals? - NasdaqIs Bio-Techne Corporation's (NASDAQ:TECH) Latest Stock Performance Being Led By Its Strong Fundamentals? - Nasdaq
nasdaq.com - May 11 at 1:10 PM
Stocks Showing Improved Relative Strength: Bio-Techne - Investors Business DailyStocks Showing Improved Relative Strength: Bio-Techne - Investor's Business Daily
investors.com - May 10 at 4:12 PM
Multisite Study Demonstrates Utility of Asuragen Kit for Identifying Variants  Linked to Spinal Muscular AtrophyMultisite Study Demonstrates Utility of Asuragen Kit for Identifying Variants Linked to Spinal Muscular Atrophy
finance.yahoo.com - May 10 at 8:19 AM
Bio-Techne Corporation (TECH) CEO Chuck Kummeth on Q3 2021 Results - Earnings Call Transcript - Seeking AlphaBio-Techne Corporation (TECH) CEO Chuck Kummeth on Q3 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 9 at 2:30 PM
Bio-Techne Corp (TECH) Q3 2021 Earnings Call Transcript - Motley FoolBio-Techne Corp (TECH) Q3 2021 Earnings Call Transcript - Motley Fool
fool.com - May 7 at 3:39 AM
Bio-Techne Corp (TECH) Q3 2021 Earnings Call TranscriptBio-Techne Corp (TECH) Q3 2021 Earnings Call Transcript
fool.com - May 7 at 1:39 AM
Bio-Techne Declares Dividend - Yahoo FinanceBio-Techne Declares Dividend - Yahoo Finance
finance.yahoo.com - May 6 at 7:35 AM
908 Devices and Bio-Techne Announce Joint Collaboration908 Devices and Bio-Techne Announce Joint Collaboration
finance.yahoo.com - May 4 at 9:08 AM
Bio-Techne and 908 Devices Announce Joint CollaborationBio-Techne and 908 Devices Announce Joint Collaboration
finance.yahoo.com - May 4 at 9:08 AM
Bio-Techne Trading Near Top Of Buy Range Ahead Of Earnings - Investors Business DailyBio-Techne Trading Near Top Of Buy Range Ahead Of Earnings - Investor's Business Daily
investors.com - April 29 at 1:49 PM
Bio-Techne Announces Commercial Release of Novel DNAscope™ in situ Hybridization Assays for Chromogenic Detection of DNA Copy Number and Structural VariationsBio-Techne Announces Commercial Release of Novel DNAscope™ in situ Hybridization Assays for Chromogenic Detection of DNA Copy Number and Structural Variations
finance.yahoo.com - April 27 at 8:21 AM
Is Bio-Techne (TECH) Stock A Buy or Sell? - Yahoo FinanceIs Bio-Techne (TECH) Stock A Buy or Sell? - Yahoo Finance
finance.yahoo.com - April 26 at 9:41 AM
Is Bio-Techne (TECH) Stock A Buy or Sell?Is Bio-Techne (TECH) Stock A Buy or Sell?
finance.yahoo.com - April 26 at 9:41 AM
This page was last updated on 7/26/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.